Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 9701-9750 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT05027763
Effect of Preoperative Diet on Perioperative Gut Microbiome
NAActive, not recruiting
60 participants
Started: Mar 1, 2022 · Completed: Sep 20, 2025
1 condition1 sponsor1 location
NCT04293016
Building Resilience In Caregivers of Trauma Survivors
NAActive, not recruiting
300 participants
Started: Mar 1, 2022 · Completed: Aug 26, 2024
1 condition2 sponsors1 location
NCT05128032
Pressure-enabled Delivery in Radioembolization (TriNav Study)
NAActive, not recruiting
20 participants
Started: Mar 1, 2022 · Completed: Jun 1, 2026
3 conditions2 sponsors2 locations
NCT05264961
Behavioral Abnormalities in Dysphonic Children
NAActive, not recruiting
25 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05176847
The Mobile Lifestyle Intervention for Food and Exercise Study
NAActive, not recruiting
240 participants
Started: Mar 1, 2022 · Completed: Sep 30, 2025
2 conditions1 sponsor1 location
NCT05459753
Cholinergic Mechanisms of Attentional-motor Integration and Gait Dysfunction in Parkinson Disease (UDALL)
NAActive, not recruiting
125 participants
Started: Mar 1, 2022 · Completed: Jun 30, 2026
2 conditions2 sponsors1 location
NCT05243550
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
PHASE3Active, not recruiting
240 participants
Started: Mar 1, 2022 · Completed: Feb 29, 2028
3 conditions1 sponsor65 locations
NCT05249075
Micro-Tech FNB Needle to Obtain Tissue Specimens of Pancreas Malignancy for Personalized Based Chemotherapy
N/AActive, not recruiting
150 participants
Started: Mar 1, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05133726
Peer and Text Message Support to Reduce Readmission Rates for Patients Discharged From Acute Psychiatric Care
NAActive, not recruiting
1,132 participants
Started: Mar 1, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors7 locations
NCT05177211
Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
PHASE2Active, not recruiting
25 participants
Started: Mar 1, 2022 · Completed: Apr 30, 2026
3 conditions2 sponsors3 locations
NCT06472635
a Neo-adjuvant Chemotherapy Immunotherapy in Resectable ESCC Study
N/AActive, not recruiting
95 participants
Started: Mar 1, 2022 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT05243680
An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)
PHASE3Active, not recruiting
641 participants
Started: Mar 1, 2022 · Completed: May 19, 2025
1 condition2 sponsors151 locations
NCT04662489
Radial Ablation for the Control of Persistent Atrial Fibrillation
NAActive, not recruiting
244 participants
Started: Mar 1, 2022 · Completed: Feb 28, 2026
1 condition4 sponsors3 locations
NCT05653167
VR as a Facilitator for Participation in Society Among Persons With MHD/SUD
N/AActive, not recruiting
124 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2024
2 conditions2 sponsors1 location
NCT05172011
Understanding the Long-term Impact of COVID on Children and Families
N/AActive, not recruiting
15,028 participants
Started: Mar 1, 2022 · Completed: May 23, 2027
1 condition2 sponsors65 locations
NCT05023538
Prevention of Heart Failure in Type 2 Diabetes by Exercise Intervention
NAActive, not recruiting
182 participants
Started: Mar 1, 2022 · Completed: Dec 1, 2026
1 condition4 sponsors2 locations
NCT04912492
Promoting Prosocial Bystander Behavior in Intoxicated Men: Evaluation of RealConsent2.0
NAActive, not recruiting
667 participants
Started: Mar 1, 2022 · Completed: Feb 28, 2026
3 conditions2 sponsors2 locations
NCT05377736
Thyroid Nodule Gene Sequencing in a Danish Population
NAActive, not recruiting
30 participants
Started: Mar 1, 2022 · Completed: Jan 18, 2027
2 conditions3 sponsors1 location
NCT03733535
Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI
NAActive, not recruiting
29 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05119569
A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)
PHASE2Active, not recruiting
109 participants
Started: Mar 1, 2022 · Completed: Dec 30, 2026
1 condition1 sponsor17 locations
NCT05294081
EFFects of EXPosure and Cognitive-behavioural Therapy for Chronic BACK Pain
NAActive, not recruiting
380 participants
Started: Mar 1, 2022 · Completed: Oct 31, 2027
1 condition2 sponsors5 locations
NCT07103122
Virtual Reality Therapy for Arm Recovery (VVITA) Stroke
NAActive, not recruiting
24 participants
Started: Mar 1, 2022 · Completed: Jun 30, 2027
1 condition8 sponsors1 location
NCT05889598
Resistance Exercise Training to Improve Bone and Articular Cartilage Health in Women
NAActive, not recruiting
110 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05236725
Monitoring and Testing of Blood Pressure in Postpartum Women
NAActive, not recruiting
1,602 participants
Started: Mar 1, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT05205031
Intravenous Vs. Intraosseous Vascular Access During Out-of-Hospital
PHASE4Active, not recruiting
1,479 participants
Started: Mar 1, 2022 · Completed: May 5, 2025
1 condition3 sponsors5 locations
NCT05237947
Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial
PHASE4Active, not recruiting
5,000 participants
Started: Mar 1, 2022 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06335004
Evaluation of Brain Waste Clearance Pathways Using Magnetic Resonance Imaging in Pediatric Patients With White Matter Diseases
N/AActive, not recruiting
100 participants
Started: Mar 1, 2022 · Completed: Feb 28, 2025
4 conditions1 sponsor1 location
NCT05277961
Quantification of DNA Repair Products in the Urine After Ultraviolet Radiation of the Skin
NAActive, not recruiting
80 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2025
4 conditions2 sponsors1 location
NCT05177991
Post-operative Pain Control-TAP Block Using Exparel vs. Marcaine for Hernia Repairs
EARLY_PHASE1Active, not recruiting
200 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT05996354
Concave Supra-arch Branched Stent-Graft System for Treatment of Aortic Arch Diseases
NAActive, not recruiting
10 participants
Started: Mar 1, 2022 · Completed: Apr 30, 2025
5 conditions1 sponsor3 locations
NCT05185531
A Study of Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma
PHASE1Active, not recruiting
20 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT06354335
Impact of a Major Organizational Change on Employee Productivity and Mental Health
N/AActive, not recruiting
31,555 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2026
3 conditions4 sponsors1 location
NCT05177731
"Venetoclax + Decitabine vs. 7+3 Induction Chemotherapy in Young AML"
PHASE3Active, not recruiting
188 participants
Started: Mar 1, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05180812
Safety and Feasibility of ExoNET
NAActive, not recruiting
20 participants
Started: Mar 1, 2022 · Completed: Jul 12, 2026
2 conditions1 sponsor1 location
NCT05285280
Echocardiography in Men With Erectile Dysfunction
N/AActive, not recruiting
386 participants
Started: Mar 1, 2022 · Completed: Mar 1, 2032
3 conditions1 sponsor1 location
NCT05260905
Predictors of Affective Responses to Sprint Interval Exercise
N/AActive, not recruiting
150 participants
Started: Mar 1, 2022 · Completed: Aug 31, 2025
1 condition5 sponsors1 location
NCT05250973
A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) Amyloidosis
PHASE2Active, not recruiting
151 participants
Started: Mar 1, 2022 · Completed: Mar 2, 2027
1 condition1 sponsor46 locations
NCT05201833
TRACK-TBI Longitudinal Biomarker Study
N/AActive, not recruiting
300 participants
Started: Mar 1, 2022 · Completed: Feb 28, 2027
1 condition3 sponsors11 locations
NCT05224102
A Study to Investigate Faricimab Treatment Response in Treatment-Naive, Underrepresented Patients With Diabetic Macular Edema
PHASE4Active, not recruiting
218 participants
Started: Feb 28, 2022 · Completed: Feb 28, 2027
1 condition1 sponsor43 locations
NCT05063916
Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix
PHASE2Active, not recruiting
18 participants
Started: Feb 28, 2022 · Completed: Aug 1, 2027
3 conditions1 sponsor1 location
NCT05040568
A PHASE IB STUDY OF IMMUNOTHERAPY WITH EX VIVO PRE-ACTIVATED AND EXPANDED CB-NK CELLS IN COMBINATION WITH CETUXIMAB, IN COLORECTAL CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE (MRD)
PHASE1Active, not recruiting
15 participants
Started: Feb 28, 2022 · Completed: Feb 2, 2027
2 conditions1 sponsor1 location
NCT04922281
Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation
NAActive, not recruiting
120 participants
Started: Feb 28, 2022 · Completed: Dec 31, 2026
5 conditions2 sponsors1 location
NCT05044039
Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
PHASE1Active, not recruiting
42 participants
Started: Feb 28, 2022 · Completed: May 31, 2030
2 conditions4 sponsors1 location
NCT04951050
TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment
NAActive, not recruiting
200 participants
Started: Feb 28, 2022 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT05167448
A Study of ES104 in Patients With Metastatic Colorectal Cancer
PHASE1/PHASE2Active, not recruiting
58 participants
Started: Feb 25, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT06030544
Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY)
PHASE2Active, not recruiting
100 participants
Started: Feb 25, 2022 · Completed: Jun 30, 2025
2 conditions3 sponsors1 location
NCT05185843
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen
PHASE3Active, not recruiting
24 participants
Started: Feb 25, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor11 locations
NCT04888988
Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy
NAActive, not recruiting
133 participants
Started: Feb 25, 2022 · Completed: Nov 7, 2025
3 conditions2 sponsors93 locations
NCT05222802
A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
PHASE1Active, not recruiting
52 participants
Started: Feb 25, 2022 · Completed: Sep 30, 2025
1 condition2 sponsors8 locations
NCT05221281
Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care
NAActive, not recruiting
90 participants
Started: Feb 25, 2022 · Completed: Dec 31, 2025
6 conditions5 sponsors3 locations